Climate change at the ecosystem scale: a 50-year record in New Hampshire

Observing the full range of climate change impacts at the local scale is difficult. Predicted rates of change are often small relative to interannual variability, and few locations have sufficiently comprehensive long-term records of environmental variables to enable researchers to observe the fine-scale patterns that may be important to understanding the influence of climate change on biological systems at the taxon, community, and ecosystem levels. We examined a 50-year meteorological and hydrological record from the Hubbard Brook Experimental Forest (HBEF) in New Hampshire, an intensively monitored Long-Term Ecological Research site. Of the examined climate metrics, trends in temperature were the most significant (ranging from 0.7 to 1.3 °C increase over 40–50 year records at 4 temperature stations), while analysis of precipitation and hydrologic data yielded mixed results. Regional records show generally similar trends over the same time period, though longer-term (70–102 year) trends are less dramatic. Taken together, the results from HBEF and the regional records indicate that the climate has warmed detectably over 50 years, with important consequences for hydrological processes. Understanding effects on ecosystems will require a diversity of metrics and concurrent ecological observations at a range of sites, as well as a recognition that ecosystems have existed in a directionally changing climate for decades, and are not necessarily in equilibrium with the current climate

Measurement of teicoplanin by liquid chromatography-tandem mass spectrometry:development of a novel method

Teicoplanin is an antibiotic used for the treatment of endocarditis, osteomyelitis, septic arthritis and methicillin-resistant Staphylococcus aureus. Teicoplanin is emerging as a suitable alternative antibiotic to vancomycin, where their trough serum levels are monitored by immunoassay routinely. This is the first report detailing the development of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for measuring teicoplanin in patients' serum

Activation of Six1 target genes is required for sensory placode formation

AbstractIn vertebrates, cranial placodes form crucial parts of the sensory nervous system in the head. All cranial placodes arise from a common territory, the preplacodal region, and are identified by the expression of Six1/4 and Eya1/2 genes, which control different aspects of sensory development in invertebrates as well as vertebrates. While So and Eya can induce ectopic eyes in Drosophila, the ability of their vertebrate homologues to induce placodes in non-placodal ectoderm has not been explored. Here we show that Six1 and Eya2 are involved in ectodermal patterning and cooperate to induce preplacodal gene expression, while repressing neural plate and neural crest fates. However, they are not sufficient to induce ectopic sensory placodes in future epidermis. Activation of Six1 target genes is required for expression of preplacodal genes, for normal placode morphology and for placode-specific Pax protein expression. These findings suggest that unlike in the fly where the Pax6 homologue Eyeless acts upstream of Six and Eya, the regulatory relationships between these genes are reversed in early vertebrate placode development

Mid-Infrared High-Contrast Imaging of HD 114174 B : An Apparent Age Discrepancy in a "Sirius-Like" Binary System

We present new observations of the faint "Sirius-like" companion discovered to orbit HD 114174. Previous attempts to image HD 114174 B at mid-infrared wavelengths using NIRC2 at Keck have resulted in a non-detection. Our new L'-band observations taken with the Large Binocular Telescope and LMIRCam recover the companion ($\Delta L$ = 10.15 $\pm$ 0.15 mag, $\rho$ = 0.675'' $\pm$ 0.016'') with a high signal-to-noise ratio (10 $\sigma$). This measurement represents the deepest L' high-contrast imaging detection at sub-arcsecond separations to date, including extrasolar planets. We confirm that HD 114174 B has near-infrared colors consistent with the interpretation of a cool white dwarf ($J-L'$ = 0.76 $\pm$ 0.19 mag, $K-L'$ = 0.64 $\pm$ 0.20). New model fits to the object's spectral energy distribution indicate a temperature $T_{\rm eff}$ = 4260 $\pm$ 360 K, surface gravity log g = 7.94 $\pm$ 0.03, a cooling age t$_{c} \approx$ 7.8 Gyr, and mass $M$ = 0.54 $\pm$ 0.01 $M_{\odot}$. We find that the cooling age given by theoretical atmospheric models do not agree with the age of HD 114174 A derived from both isochronological and gyrochronological analyses. We speculate on possible scenarios to explain the apparent age discrepancy between the primary and secondary. HD 114174 B is a nearby benchmark white dwarf that will ultimately enable a dynamical mass estimate through continued Doppler and astrometric monitoring. Efforts to characterize its physical properties in detail will test theoretical atmospheric models and improve our understanding of white dwarf evolution, cooling, and progenitor masses.Comment: 6 pages, 3 figures, to be published in the Astrophysical Journal Letter

Therapeutic efficacy of favipiravir against Bourbon virus in mice

Bourbon virus (BRBV) is an emerging tick-borne RNA virus in the orthomyxoviridae family that was discovered in 2014. Although fatal human cases of BRBV have been described, little is known about its pathogenesis, and no antiviral therapies or vaccines exist. We obtained serum from a fatal case in 2017 and successfully recovered the second human infectious isolate of BRBV. Next-generation sequencing of the St. Louis isolate of BRBV (BRBV-STL) showed >99% nucleotide identity to the original reference isolate. Using BRBV-STL, we developed a small animal model to study BRBV-STL tropism in vivo and evaluated the prophylactic and therapeutic efficacy of the experimental antiviral drug favipiravir against BRBV-induced disease. Infection of Ifnar1-/- mice lacking the type I interferon receptor, but not congenic wild-type animals, resulted in uniformly fatal disease 6 to 10 days after infection. RNA in situ hybridization and viral yield assays demonstrated a broad tropism of BRBV-STL with highest levels detected in liver and spleen. In vitro replication and polymerase activity of BRBV-STL were inhibited by favipiravir. Moreover, administration of favipiravir as a prophylaxis or as post-exposure therapy three days after infection prevented BRBV-STL-induced mortality in immunocompromised Ifnar1-/- mice. These results suggest that favipiravir may be a candidate treatment for humans who become infected with BRBV